References
- 1. SACCO RL., KASNER SE., BRODERICK JP., CAPLAN LR., CONNORS JJ., CULEBRAS A., et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke.2013; 44:2064–89.
- 2. 2MOZAFFARIAN D., BENJAMIN EJ., GO AS., ARNETT DK., BLAHA MJ., CUSHMAN M., et al. Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation.2016;133(4):e38–360.
- 3. LADEBY R., WIRENFELDT M, GARCIA-OVEJERO D, FENGER C, DISSING-OLESEN L, DALMAU I, et al. Microglial cell population dynamics in the injured adult central nervous system. Brain Res Brain Res Rev.2005; 48:196–206.
- 4. KENDRICK J, TARGHER G, SMITS G, CHONCHOL M., 25- Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis.2009; 205:255–260.
- 5. DURUP D, JØRGENSEN HL, CHRISTENSEN J, TJØNNELAND A, OLSEN A., HALKJÆR J, et al. A Reverse J-Shaped Association Between Serum 25-Hydroxyvitamin D and Cardiovascular Disease Mortality: The CopD Study. J ClinEndocrinolMetab. 2015;100:2339–2346.
- 6. TARCIN O., YAVUZ DG., OZBEN B., TELLI A., OGUNC AV., YUKSEL M., TOPRAK A, et al. Effect of Vitamin D Deficiency and Replacement on Endothelial Function in Asymptomatic Subjects. J Clin Endocrinol Metab.2009; 94:4023–4030.
- 7. MITRI J., MURARU MD., PITTAS AG., Vitamin D and type 2 diabetes: a systematic review. Eur J Clin Nutr.2011; 65: 1005–1015.
- 8. ZITTERMANN A., GUMMERT JF., BORGERMANN J., The Role of Vitamin D in Dyslipidemia and Cardiovascular Disease. Curr Pharm Des.2011; 17: 933–942.
- 9. MARTINS D., WOLF M., PAN D., ZADSHIR A., TAREEN N., THADHANI R., et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med.2007;167:1159–1165.
- 10. MARNIEMI J., ALANEN E., IMPIVAARA O., SEPPÄNEN R., HAKALA P., RAJALA T., et al. Dietary and serum vitamins and minerals as predictors of myocardial infarction and stroke in elderly subjects.NutrMetabCardiovasc Dis.2005;15:188–197.
- 11. SUN Q., PAN A., HU FB., MANSON JE., REXRODE KM.. 25-Hydroxyvitamin D Levels and the Risk of Stroke: A Prospective Study and Meta-analysis.Stroke. 2012; 43(6):1470–7.
- 12. BRØNDUM-JACOBSEN P., NORDESTGAARD BG., SCHNOHR P., BENN M., 25-hydroxyvitamin D and symptomatic ischemic stroke: an original study and meta-analysis. Ann Neurol.2013; 73:38–47.
- 13. CHAUDHURI JR., MRIDULA KR., ALLADI S., ANAMIKA A., UMAMAHESH M., BALARAJU B., et al. Serum 25- hydroxyvitamin d deficiency in ischemic stroke and subtypes in Indian patients. J Stroke.2014;16(1):44–50.
- 14. TU W-J., ZHAO S-J., XU D-J., CHEN H., Serum 25-hydroxyvitamin D predicts the short-term outcomes of Chinese patients with acute ischaemic stroke.ClinSci (Lond).2014; 126:339–46.
- 15. TURETSKY A., GODDEAU RP., HENNINGER N. Low Serum Vitamin D Is Independently Associated with Larger Lesion Volumes after Ischemic Stroke. J Stroke Cerebrovasc Dis.2015; 24:1555–1563.
- 16. PARK KY., CHUNG PW., KIM YB., MOON HS., SUH BC., WON YS., et al. Serum Vitamin D Status as a Predictor of Prognosis in Patients with Acute Ischemic Stroke. Cerebrovasc Dis.2015; 40:73–80.
- 17. HOLICK M., Vitamin D deficiency. N Engl J Med.2007; 357:266–81.
- 18. EBELING PR., Vitamin D and bone health: Epidemiologic studies. BoneKEy Rep.2014; 3:511.
- 19. COHEN-LAHAV M., SHANY S., TOBVIN D., CHAIMOVITZ C., DOUVDEVANI A., et al. Vitamin D decreases NFkappaB activity by increasing IkappaBalpha levels.Nephrol Dial Transplant.2006; 21:889–97.Epub 2006 Feb 2.
- 20. LIU X., NELSON A., WANG X., FARID M., GUNJI Y., IKARI J, et al. Vitamin D modulates prostaglandin E2 synthesis and degradation in human lung fibroblasts. Am J Respir Cell Mol Biol. 2014; 50:40–50.
- 21. HUANG Y-N, HO Y-J, LAI C-C, CLIU CT. WANG JY. 1,25-Dihydroxyvitamin D3 attenuates endotoxin-induced production of inflammatory mediators by inhibiting MAPK activation in primary cortical neuron-glia cultures. J Neuroinflammation.2015; 12:147.
- 22. BOONSTRA A, BARRAT FJ, CRAIN C, HEATH VL, SAVELKOUL HF, O’GARRA A. 1alpha, 25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol. 2001;167:4974–4980.
- 23. MARNIEMI J1, ALANEN E, IMPIVAARA O, SEPPÄNEN R, HAKALA P, RAJALA T, et al. Dietary and serum vitamins and minerals as predictors of myocardial infarction and stroke in elderly subjects.NutrMetabCardiovasc Dis.2005; 15:188–97.
- 24. MICHOS ED, REIS JP, POST WS, LUTSEY PL, GOTTESMAN RF, MOSLEY TH, et al. 25-Hydroxyvitamin D deficiency is associated with fatal stroke among whites but not blacks: The NHANES-III linked mortality files. Nutrition.2012;28(4):367–71.
- 25. DAUBAIL B, JACQUIN A, GUILLAND JC, KHOUMRI C, ABOA-EBOULÉ C, GIROUD M, et al. Association between serum concentration of vitamin D and 1-year mortality in stroke patients. Cerebrovasc Dis.2014; 37:364–7.
- 26. WANG Y, JI H, TONG Y, ZHANG Z. Prognostic Value of Serum 25-Hydroxyvitamin D in Patients with Stroke.Neurochem Res.2014; 39: 1332–1337.
- 27. TURETSKY A, GODDEAU RP, HENNINGER N. Low Serum Vitamin D Is Independently Associated with Larger Lesion Volumes after Ischemic Stroke. J Stroke Cerebrovasc Dis.2015; 24:1555–1563.
- 28. BOLLAND MJ, BACON CJ, HORNE AM, MASON BH, AMES RW, WANG TK, et al. Vitamin D deficiency and health outcomes over 5 y in older women. Am J Clin Nutr.2010; 91: 82–89.
- 29. DRECHSLER C, PILZ S, OBERMAYER-PIETSCH B, VERDUIJN M, TOMASCHITZ A, KRANE V, et al. Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients. Eur Heart J.2010; 31: 2253–2261.
- 30. KÜHN T, KAAKS R, TEUCHER B, HIRCHE F, DIERKES J, WEIKERT C, et al. Plasma 25-Hydroxyvitamin D and Its Genetic Determinants in Relation to Incident Myocardial Infarction and Stroke in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Germany Study. PLoS One.2013; 8:1–12
- 31. GUPTA A, PRABHAKAR S, MODI M, BHADADA SK, LAL V, KHURANA D. Vitamin D status and risk of ischemic stroke in North Indian patients. Indian J EndocrinolMetab2014;18:721–5.doi: 10.4103/2230-8210.139241.
- 32. MAJUMDAR V, PRABHAKAR P, KULKARNI GB, CHRISTOPHER R. Vitamin D status, hypertension and ischemic stroke: a clinical perspective. J Hum Hypertens. 2015;29(11):669–674.
- 33. ODDERSON IR. The National Institutes of Health Stroke Scale and its importance in acute stroke management. Phys Med RehabilClin N Am. 1999; 10(4):787–800, vii.
- 34. BANKS JL1, MAROTTA CA. Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke. 2007;38(3):1091–6.
- 35. POOLE KE, LOVERIDGE N, BARKER PJ, HALSALL DJ, ROSE C, REEVE J, et al. Reduced vitamin D in acute stroke. Stroke.2006;37:243–245.
- 36. SUN Q, PAN A, HU FB, MANSON JE, REXRODE KM. 25-Hydroxyvitamin D levels and the risk of stroke: a prospective study and meta-analysis. Stroke.2012;43:1470–1477.
- 37. BUELL JS, DAWSON-HUGHES B, SCOTT TM, WEINER DE, DALLAL GE, QUI WQ, et al. 25 Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology.2010;74:18–26.
- 38. BONAKDARAN S, VARSTEH AR. Correlation between serum 25-hydroxy vitamin D3 and laboratory risk markers of cardiovascular diseases in type 2 diabetic patients. Saudi Med J. 2009;30:509–514.
- 39. CARRELLI AL, WALKER MD, LOWE H, MCMAHON DJ, RUNDEK T, SACCO RL, et al. Vitamin D deficiency is associated with subclinical carotid atherosclerosis: the Northern Manhattan study. Stroke.2011;42:2240–2245.
- 40. MARTINS D, WOLF M, PAN D, ZADSHIR A, TAREEN N, THADHANI R, et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2007; 167:1159–1165.
- 41. ZITTERMANN A, TENDERICH G, BERTHOLD HK, KORFER R, STEHLE P. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J Am CollCardiol. 2003;41:105–112.
- 42. KIM DH, SABOUR S, SAGAR UN, ADAMS S, WHELLAN DJ. Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). Am J Cardiol. 2008;102:1540–1544.
- 43. GIOVANNUCCI E, LIU Y, HOLLIS BW, RIMM EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med. 2008;168:1174–1180.
- 44. DE BOER IH, KESTENBAUM B, SHOBEN AB, MICHOS ED, SARNAK MJ, SISCOVICK DS. 25-hydroxyvitamin D levels inversely associated with risk for developing coronary artery calcification. J Am Soc Nephrol.2009;20:1805–1812.
- 45. MICHOS ED, MELAMED ML. Vitamin D and cardiovascular disease risk. CurrOpinClinNutrMetab Care. 2008;11:7–12.
- 46. MARCÉN R, JIMENEZ S, FERNÁNDEZ-RODRIGUEZ A, GALEANO C, VILLAFRUELA JJ, GOMIS A, et al. Are low levels of 25-hydroxyvitamin D a risk factor for cardiovascular diseases or malignancies in renal transplantation? Nephrol Dial Transplant.2012;27(Suppl 4):iv47–iv52.
- 47. KÜHN T, KAAKS R, TEUCHER B, HIRCHE F, DIERKES J, WEIKERT C, et al. Plasma 25-hydroxyvitamin D and its genetic determinants in relation to incident myocardial infarction and stroke in the European prospective investigation into cancer and nutrition (EPIC)-Germany study. PLoS One.2013;8:e69080.
- 48. LI YC, KONG J, WEI M, CHEN ZF, LIU SQ, CAO LP. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002;110:229–238.
- 49. AIHARA K, AZUMA H, AKAIKE M, IKEDA Y, YAMASHITA M, SUDO T, et al. Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice. J Biol Chem. 2004;279:35798–35802.
- 50. WATSON KE, ABROLAT ML, MALONE LL, HOEG JM, DOHERTY T, DETRANO R, et al. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation. 1997; 96:1755–1760.
- 51. MERKE J, HOFMANN W, GOLDSCHMIDT D, RITZ E. Demonstration of 1,25(OH)2 vitamin D3 receptors and actions in vascular smooth muscle cells in vitro. Calcif Tissue Int.1987; 41:112–114.
- 52. RIGBY WF, DENOME S, FANGER MW. Regulation of lymphokine production and human T lymphocyte activation by 1, 25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA. J Clin Invest.1987;79:1659–1664.
- 53. JOUNI ZE, WINZERLING JJ, MCNAMARA DJ. 1, 25-Dihydroxyvitamin D3-induced HL-60 macrophages: regulation of cholesterol and LDL metabolism. Atherosclerosis.1995; 117:125–138.
- 54. VILA N, CASTILLO J, DÁVALOS A, CHAMORRO A. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Strok. 2000; 31:2325–2329.
- 55. NEVEU I, NAVEILHAN P, JEHAN F, BAUDET C, WION D, DE LUCA HF, et al. 1,25-dihydroxyvitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells. Brain Res Mol Brain Res.1994; 24:70–6.
- 56. BALDEN R, SELVAMANI A, SOHRABJI F. Vitamin D deficiency exacerbates experimental stroke injury and dysregulates ischemia-induced inflammation in adult rats. Endocrinology.2012; 153:2420–2435.